Regulatory conditions met for Novo Holdings' $16.5 billion Catalent deal, companies say By Reuters
(Reuters) - All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. drugmaker Catalent (NYSE:) have been ...
(Reuters) - All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. drugmaker Catalent (NYSE:) have been ...
<img src="https://crypto.news/app/uploads/2023/07/bullish_-markets04.jpg" /> As cryptocurrency prices rise amid optimism, 10T Holdings founder Dan Topiero says Q4 will be “the best ...